Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 12.35M
April 30, 2026 15.70M
January 31, 2026 16.98M
October 31, 2025 18.63M
July 31, 2025 29.47M
April 30, 2025 32.17M
January 31, 2025 31.44M
October 31, 2024 43.02M
July 31, 2024 42.93M
April 30, 2024 43.66M
January 31, 2024 58.90M
October 31, 2023 54.46M
July 31, 2023 58.18M
April 30, 2023 57.37M
January 31, 2023 61.78M
October 31, 2022 60.67M
July 31, 2022 62.39M
April 30, 2022 73.27M
January 31, 2022 44.38M
October 31, 2021 48.67M
July 31, 2021 51.62M
April 30, 2021 54.43M
January 31, 2021 34.13M
October 31, 2020 32.78M
July 31, 2020 24.95M
Date Value
April 30, 2020 19.63M
January 31, 2020 19.33M
October 31, 2019 20.06M
July 31, 2019 21.22M
April 30, 2019 21.07M
January 31, 2019 22.04M
October 31, 2018 23.64M
July 31, 2018 18.35M
April 30, 2018 19.17M
January 31, 2018 10.66M
October 31, 2017 10.28M
July 31, 2017 2.405M
April 30, 2017 2.874M
January 31, 2017 3.510M
June 30, 2016
March 31, 2016
December 31, 2015 0.0111M
September 30, 2015 0.0147M
June 30, 2015 0.0249M
March 31, 2015 0.0354M
December 31, 2014 0.0398M
September 30, 2014 0.042M
June 30, 2014 0.096M
March 31, 2014 0.1172M
December 31, 2013 0.1339M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Repligen Corp. 2.950B
Bio-Techne Corp. 2.679B
BioLife Solutions, Inc. 447.49M
Maravai Lifesciences Holdings, Inc. 603.75M
MaxCyte, Inc. 184.67M

Total Assets (Quarterly) Related Metrics